Get started
Keyword

HER2 testing

Description: Clinical laboratory assessment of human epidermal growth factor receptor 2 status to guide cancer diagnosis and treatment.
OpenAlex ID: keywords/her2-testing
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
2006 · Antonio C. Wolff, M. Elizabeth H. Hammond, et al. · Journal of Clinical Oncology · 4,434
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 · Antonio C. Wolff, M. Elizabeth H. Hammond, et al. · Journal of Clinical Oncology · 4,031
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 · Antonio C. Wolff, M. Elizabeth Hale Hammond, et al. · Journal of Clinical Oncology · 2,439
PDF
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
2007 · Antonio C. Wolff, M. Elizabeth H. Hammond, et al. · Archives of Pathology & Laboratory Medicine · 1,816
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 · Antonio C. Wolff, M. Elizabeth H. Hammond, et al. · Archives of Pathology & Laboratory Medicine · 1,763
PDF
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 · Antonio C. Wolff, M. Elizabeth Hale Hammond, et al. · Archives of Pathology & Laboratory Medicine · 1,476
PDF
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update
2023 · Antonio C. Wolff, Mark R. Somerfield, et al. · Journal of Clinical Oncology · 698
HER2: Biology, Detection, and Clinical Implications
2011 · Carolina Gutierrez, Rachel Schiff · Archives of Pathology & Laboratory Medicine · 653
HER2 testing in gastric cancer: a practical approach
2012 · Josef Rüschoff, Wedad Hanna, et al. · Modern Pathology · 595
PDF
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
2021 · Carsten Denkert, Fenja Seither, et al. · The Lancet Oncology · 553
Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
2009 · Guido Sauter, James Lee, et al. · Journal of Clinical Oncology · 509
PDF
Real-World Performance of HER2 Testing--National Surgical Adjuvant Breast and Bowel Project Experience
2002 · S. Paik, J. Bryant, et al. · JNCI Journal of the National Cancer Institute · 484
PDF
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
2017 · Angela N. Bartley, Mary Kay Washington, et al. · Journal of Clinical Oncology · 461
HER2 Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial
2006 · Edith A. Perez, Vera J. Suman, et al. · Journal of Clinical Oncology · 438
PDF
An Introduction to the Performance of Immunohistochemistry
2018 · Shino Magaki, Seyed A. Hojat, et al. · Methods in molecular biology · 419
PDF
Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831
2002 · P. C. Roche, V. J. Suman, et al. · JNCI Journal of the National Cancer Institute · 390
PDF
A Phase II Study of Trastuzumab Emtansine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab, Lapatinib, an Anthracycline, a Taxane, and Capecitabine
2012 · Ian E. Krop, Patricia LoRusso, et al. · Journal of Clinical Oncology · 366
PDF
HER2-positive gastric cancer
2013 · Narikazu Boku · Gastric Cancer · 351
PDF
Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
2012 · Hyesil Seol, Hyun Ju Lee, et al. · Modern Pathology · 330
PDF
HER2 in Breast Cancer
2014 · Uma Krishnamurti, Jan F. Silverman · Advances in Anatomic Pathology · 328
Chemo- and Regioselective Lysine Modification on Native Proteins
2018 · Maria J. Matos, Bruno L. Oliveira, et al. · Journal of the American Chemical Society · 314
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
2023 · Antonio C. Wolff, Mark R. Somerfield, et al. · Archives of Pathology & Laboratory Medicine · 296
PDF
Current Perspectives on HER2 Testing: A Review of National Testing Guidelines
2003 · Michael Bilous, Mitch Dowsett, et al. · Modern Pathology · 264
PDF
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
2016 · Angela N. Bartley, Mary Kay Washington, et al. · Archives of Pathology & Laboratory Medicine · 254
Bimetallic Single-Atom Nanozyme-Based Electrochemical-Photothermal Dual-Function Portable Immunoassay with Smartphone Imaging
2024 · Yunsen Wang, Ruijin Zeng, et al. · Analytical Chemistry · 239
Works count: 1,395
Citation count: 43,950
Year
Topic
Type